@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT
@theverge.com 7 years ago
CRISPR patents, potentially worth billions, belong to Broad Institute